Biomed 21
Dijon, 21000, France
NCT Number: NCT04862338
The purpose of this study is to evaluate the physiological and/or biological actions of nicotinamide mononucleotide (NMN-C) in healthy adults receiving a repeated-dose over the course of 28 days by studying the tolerance and pharmacodynamics of this product.
Looking for future studies?
Notify Me30 year–60 year
All sexes
Interventional
Not applicable
Dijon, 21000, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Healthy volunteers should be
Exclusion criteria
May not be included in the study Volunteers with
Nicotinamide mononucleotide (NMN-C) at 400 mg/day for 28 days in total
Time frame: Day 0, Day 14 and Day 28
Time frame: Day 0, Day 14 and Day 28
Time frame: Day 0, Day 14 and Day 28
MeNAM, NAM, DMG, TMG and Homocystein
Time frame: Day -7, Day 14 and Day 28
MeNAM and Me-2-PY
Time frame: Day 14 and Day 28
Evaluation of adverse events
Time frame: Day 0 and Day 28
mitochondrial DNA ratio will be assessed in the epithelial cells collected by buccal swabs
Time frame: Day -7, Day 14 and Day 28
Time frame: Day -7, Day 14 and Day 28
Triglycerides, Total Cholesterol, HDL-Cholesterol, LDL-Cholesterol
Time frame: Day -7, Day 14 and Day 28
Time frame: Day -7, Day 14 and Day 28
Time frame: Day -7, Day 14 and Day 28
Time frame: Day -7, Day 14 and Day 28
Time frame: Day -7, Day 14 and Day 28
Time frame: Day -7, Day 14 and Day 28
Potassium, Chloride, Sodium levels will be assessed in blood
Time frame: Day -7 and Day 28
Time frame: Day -7 and Day 28
Time frame: Day -7 and Day 28
Time frame: Day -7, Day 14 and Day 28
Time frame: Day -7, Day 14 and Day 28
Body composition will be assessed by impedancemetry
Seneque SA
Industry
Pharmacodynamics and Tolerance Study of Nicotinamide Mononucleotide (NMN) Supplementation at 400 mg/Day
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05447078
Healthy Volunteers, Infections
Jackson, Mississippi, United States
View Trial DetailsNCT07513532
Healthy Volunteers
Seattle, Washington, United States
View Trial DetailsNCT07090655
Healthy Volunteers
Brisbane, Australia
View Trial DetailsNCT01915212
Communicable Diseases, DNA Virus Infections
Bethesda, Maryland, United States
View Trial Details